Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 25 June

Jessica Amir
June 25, 2020

Morning Bell 24 June

Jessica Amir
June 24, 2020

Morning Bell 23 June

Jessica Amir
June 23, 2020

Morning Bell 22 June

Sally Garrow
June 22, 2020

Weekly Wrap 19 June

Jessica Amir
June 19, 2020

Morning Bell 19 June

Jessica Amir
June 19, 2020

Morning Bell 18 June

Jessica Amir
June 18, 2020

Morning Bell 17 June

Jessica Amir
June 17, 2020

Morning Bell 16 June

Jessica Amir
June 16, 2020

Morning Bell 15 June

Jessica Amir
June 15, 2020

Weekly Wrap 12 June

Jessica Amir
June 12, 2020

Morning Bell 12 June

Jessica Amir
June 12, 2020